Medtronic has announced FDA approval of the Enlite sensor with iPro2 Professional Continuous Glucose Monitoring (CGM) system. The sensor is a disposable glucose sensor. It provides the user with more ...

Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

Medtronic’s CEO, Omar Ishrak, has long expressed a desire to expand the Irish medtech company’s footprint into the much larger type 2 diabetes market. And over the years, the company has made strides ...

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with ...

New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

Back in the day – roughly around 2007, Medtronic offered a standalone continuous glucose monitoring system where diabetics who were not using a Medtronic insulin pump could use it to get continuous ...

Medtronic received FDA approval for its Enlite sensor for use with the firm’s iPro2 professional continuous glucose monitoring system. Previously available with the MiniMed 530G insulin pump, the ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite™ Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 ...

DUBLIN - June 8, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced that it has initiated the company`s pivotal trial for its next-generation Guardian(TM) continuous ...

GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug ...